Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Different Doses of Aromatase Inhibitor Letrozole for the Treatment of Ectopic Pregnancy

NCT05198141 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT05198141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05198141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Different Doses of Aromatase Inhibitor Letrozole for the Treatment of Ectopic Pregnancy
Lead sponsor
Zagazig University
Phase
Phase 4
Overall status
Completed
Start date
December 15, 2020
Completion date
January 1, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ectopic pregnancy